Current position:Home > Selling > Raloxifene hydrochloride
CAS No:82640-04-8 [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-<br />ylethoxy)phenyl]methanone
Add to My Favorites

Raloxifene hydrochloride

  • CAS No.: 82640-04-8
  • Purity: 99%
  • Min quantity: 5000 Kilograms
  • Price: USD 1~100/Kilograms
  • Place of Orign: JiNan,Shandong,China
Ms.Sherry Lee

Supplier Details

View the Seller's Store
Product Details
Company Profile

Item specifics

  • Product Name.:Raloxifene hydrochloride
  • CAS No: 82640-04-8
  • Weight: 510.04422
  • Formula: C28H28ClNO4S
  • Melting Point: 143-147 deg C
  • Boiling Point: 728.2 °C at 760 mmHg
  • Density: 1.285g/cm3

Details


Alias: Raloxifene hydrochloride,Raloxifene HCl
CAS Registry Number: 82640-04-8
Assay: 99%
Molecular Formula: C28H28ClNO4S
Molecular weight: 510.05
Appearance: white crystalline powder
Grade:Pharmaceutical Grade


Raloxifene (marketed as Evista) is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer.

This drug is different from hormones (including estrogens and progestins). It works by acting like estrogen (as a selective estrogen receptor modulator or SERM) in some parts of the body. Raloxifene helps to preserve bone mass, but it does not affect the breast and uterus like estrogen or relieve symptoms of menopause such as hot flashes.

Raloxifene is indicated for the treatment and prevention of osteoporosis in postmenopausal women. It is also used for reduction of risk and treatment of invasive breast cancer, and it also reduces breast density.For either osteoporosis treatment or prevention, supplemental calcium and/or vitamin D should be added to the diet if daily intake is inadequate.

Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause. Maintaining strong bones by slowing bone loss helps to reduce the risk of fractures.

Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive) in women after menopause.

Permanent link:

Company Related ProductsView the Seller's Products

Raloxifene

CAS No: 84449-90-1

Purity: 99%

Min quantity: 5000 null

Price: 1 ~ 100 USD

Description: Product Name:Raloxifene Alias:Evista CAS NO.:84449-90-1 Molecular Formula:C28H27NO4S Molecular Weight:473.58 Purity:99% Appearance:Light Yellow Powder Grade:Pharmaceutical Grade Oral SERM Raloxifene is an oral selective estrogen receptor modulator (S...

Detail more >>
Send message to this supplier

CAS No:82640-04-8 [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-<br />ylethoxy)phenyl]methanone

Ms.Sherry Lee
View the Seller's Store
- Enter between 20 to 3,000 characters. English only.
Your message must be between 20-2000 characters.English only.

Related Products